ホーム>>Signaling Pathways>> PROTAC>> PROTAC Linker>>L-Azidohomoalanine hydrochloride

L-Azidohomoalanine hydrochloride

カタログ番号GC50512

L-アジドホモアラニン塩酸塩は、PROTAC の合成に使用できるアルキル鎖ベースの PROTAC リンカーです。

Products are for research use only. Not for human use. We do not sell to patients.

L-Azidohomoalanine hydrochloride 化学構造

Cas No.: 942518-29-8

サイズ 価格 在庫数 個数
10mM (in 1mL Water)
$109.00
在庫あり
50 mg
$99.00
在庫あり
100 mg
$162.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Unnatural amino acid. Incorporated into proteins during de novo protein synthesis, with no effect on protein degradation. Requires methionine-free medium for efficient incorporation. Substrate for wild-type methionyl-tRNA synthetase (MetRS) in vivo. Can be used in BONCAT (bio-orthogonal non-canonical amino acid tagging) for the identification of newly synthesized proteins.

Dieterich et al (2006) Selective identification of newly synthesized proteins in mammalian cells using bioorthogonal noncanonical amino acid tagging (BONCAT). Proc.Natl.Acad.Sci.U.S.A. 103 9482 PMID:16769897 |Lang & Chin et al (2014) Cellular incorporation of unnatural amino acids and bioorthogonal labeling of proteins. Chem.Rev. 114 4764 PMID:24655057 |Wang et al (2017) Nonradioactive quantification of autophagic protein degradation with L-azidohomoalanine labeling. Nat.Protoc. 12 279 PMID:28079880

レビュー

Review for L-Azidohomoalanine hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 39 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for L-Azidohomoalanine hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.